Health And Medicine
-
STINGing combination for cancer
A novel immunotherapy combination induced remarkable regression of tumors in a mouse model of head and neck cancer. Read MoreJun 19, 2017
-
Heart disease incidence down for men in Tennessee
There's good and bad news in the new Tennessee Men's Health Report Card. Read MoreJun 14, 2017
-
PET imaging to predict tumor response
A PET probe that detects the amino acid glutamine predicts whether tumors respond to certain targeted therapies in preclinical animal models. Read MoreJun 14, 2017
-
Drug developed for arthritis could be first to stop heart valve calcification
The first drug to treat calcification of heart valves may be one originally designed for rheumatoid arthritis. Read MoreJun 12, 2017
-
Repriming replication roadblocks
New findings shed light on how enzymes that replicate DNA skip over mutations that might cause cancer and restart DNA synthesis further away. Read MoreJun 12, 2017
-
Flip side of gut protection
Vanderbilt investigators report that dysregulation of certain immune cells in the intestines may lead to inflammation and disease. Read MoreJun 9, 2017
-
NIDDK renews Vanderbilt’s diabetes research grant
The Vanderbilt Diabetes Research and Training Center (VDRTC) is celebrating its 44th year of operation with a five-year competitive renewal of its $9 million grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the National Institutes of Health (NIH). Read MoreJun 8, 2017
-
Vanderbilt-led study disputes link between uterine fibroids and miscarriage risk
A 10-year study, led by Vanderbilt University Medical Center professor of Obstetrics and Gynecology Katherine Hartmann, M.D., Ph.D., disrupts conventional wisdom that uterine fibroids cause miscarriages. Read MoreJun 7, 2017
-
Forum highlights innovative approaches to bolstering biomedical research
How can we — together — make research at Vanderbilt University Medical Center (VUMC) better and stronger? Read MoreJun 1, 2017
-
Preserving NIH’s Fogarty International Center crucial for global health efforts
This week Douglas Heimburger, M.D., M.S., professor of Medicine at Vanderbilt, joined a growing chorus calling for preservation of the Fogarty International Center of the National Institutes of Health (NIH). Read MoreMay 26, 2017
-
Research delves into mental states of self-transcendent experiences
Researchers have, for the first time, described the similarity of different self-transcendent experiences — mental states that range from being in love to spiritual enlightenment — along a common continuum and spectrum of intensity. Read MoreMay 25, 2017
-
Study reveals role for stem cells in chronic lung diseases
A novel population of lung stem cells plays an important role in regulating the pulmonary microvasculature — the network of tiny blood vessels where oxygen and carbon dioxide exchange takes place. Read MoreMay 25, 2017
-
Oxidative stress in tumors
Vanderbilt investigators have developed a new method for measuring oxidative stress in human tumors, which provides insight into cancer development. Read MoreMay 18, 2017
-
Blood type link to cancer survival
Blood type A was associated with longer ovarian cancer survival in a recent Vanderbilt-led study. Read MoreMay 17, 2017
-
RSV-HRV viral interference
RSV infection reduces the risk of infection with human rhinovirus, which could have implications for vaccine development and prevention strategies for viral respiratory tract infections in infants. Read MoreMay 15, 2017
-
EETs contribute to insulin sensitivity
Interventions that increase circulating levels of compounds called EETs may improve insulin sensitivity and treat hypertension. Read MoreMay 11, 2017
-
Study finds male infants at increased risk for NAS
Male infants are more likely at birth than their female counterparts to be diagnosed with drug withdrawal symptoms, also known as neonatal abstinence syndrome (NAS), and to require treatment, according to a new Vanderbilt study published in Hospital Pediatrics. Read MoreMay 4, 2017
-
Study seeks to reverse precancerous stomach lesions
Vanderbilt University Medical Center cancer researcher James Goldenring, M.D., Ph.D., has received a two-year, $200,000 grant from the DeGregorio Family Foundation in Pleasantville, New York, to begin clinical trials of a potential approach for reversing precancerous stomach lesions. Read MoreMay 4, 2017
-
New cell model to help test reproductive disease therapies
Kevin Osteen, Ph.D., Pierre Soupart Professor Obstetrics and Gynecology, and his team at the Women’s Reproductive Health Research Center have developed a three-dimensional organ-on-a-chip cell model that mimics the endometrial lining of the uterus in an effort to test therapeutic interventions for reproductive diseases. Read MoreMay 4, 2017
-
Therapeutic targets for diabetes
Vanderbilt investigators have identified novel regulators of insulin-producing beta-cell proliferation and survival, suggesting new targets for the treatment of type 2 diabetes. Read MoreMay 3, 2017